Left ventricular function in patients with polycystic ovary syndrome: A Doppler echocardiographic study

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 4, 2009, Pages 165-169

  Tekin, A ^a   Tekin, G ^a   Colkesen Y ^a   Kilicdag E B ^a   Bashan I ^a   Sezgin, A T ^a   Muderrisoglu H ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Diastolic function; Echocardiography; Left ventricle; Polycystic ovary

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTERMETHOD COMPARISON; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING; BLOOD; BLOOD PRESSURE; DIASTOLE; ECHOGRAPHY; METHODOLOGY; MITRAL VALVE; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; THYROTROPIN;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MITRAL VALVE; POLYCYSTIC OVARY SYNDROME; PROLACTIN; REFERENCE VALUES; TESTOSTERONE; THYROTROPIN; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 67651229828     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-2008-1080923     Document Type: Article

References (24)

1. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN, PCOS/Troglitazone Study Group. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001; 86: 1626-1632
2. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004; 351: 1097-1105
3. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003; 18: 2289-2293
4. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84: 1897-1899
5. Celik O, Sahin I, Celik N, Hascalik S, Keskin L, Ozcan H, Uckan A, Kosar F. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study. Hum Reprod 2007; 22: 2992-2998
6. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37: 119-125
7. Cussons AJ, Stuckey BG, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 2006; 185: 227-239
8. Dahlgren E, Janson PO, Johansson S, Lapidus L, Odén A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992; 71: 599-604
9. De Boeck BW, Cramer MJ, Oh JK, Aa RP van der, Jaarsma W. Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am Heart J 2003; 146: 411-419
10. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-1174
11. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236
12. Franks S. Are women with polycystic ovary syndrome at increased risk of cardiovascular disease? Too early to be sure, but not too early to act!. Am J Med 2001; 11: 665-666 (Pubitemid 34088080)
13. Garcia MJ, Ares MA, Asher C, Rodriguez L, Vandervoort P, Thomas JD. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 1997; 29: 448-454
14. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod 1996; 11: 23-28
15. Legro RS, Kunselman AR, Dunaif A. Prevalance and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111: 607-613
16. Orio Jr F, Palomba S, Spinelli L, Cascella T, Tauchmanovà L, Zullo F, Lombardi G, Colao A. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004; 89: 3696-3701
17. Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol 2001; 54: 447-453
18. Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston DG, Franks S. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 1996; 44: 277-284
19. Sampson M, Kong C, Patel A, Unwin R, Jacobs HS. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol 1996; 45: 623-629
20. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 1998; 51: 415-422
21. Tíras MB, Yalcìn R, Noyan V, Maral I, Yìldì rìm M, Dörtlemez O, Daya S. Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 1999; 14: 1949-1952
22. Topcu S, Caliskan M, Ozcimen EE, Tok D, Uckuyu A, Erdogan D, Gullu H, Yildirir A, Zeyneloglu H, Muderrisoglu H. Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease? Hum Reprod 2006; 21: 930-935
23. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61: 946-951
24. Yarali H, Yildirir A, Aybar F, Kabakçi G, Bükülmez O, Akgül E, Oto A. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 2001; 76: 511-516